2 The Wegovy SmPC confirms no dose adjustment is needed
Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F., Jensen, C., & Wilding, J
Anne Zauderer In This Issue: A Lack of Accountability by Charles T
Currently, three main categories of gene therapies targeting p53 have been developed: adenovirus-based therapies, nanoparticles, nonviral approaches for p53 gene delivery, and CRISPRCas9-based therapies
It's important to note that Mounjaro is currently only FDA-approved for to treat Type 2 diabetes, so you will only be eligible for the savings card if you have a Type 2 diabetes diagnosis